Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| LEE HEDGES PLC | SHAW.N0000 | Colombo S.E. | 4,158 |
90
LKR
 | Stock | |
| LEE FEED MILL | LEE | Thailand S.E. | 178,678 |
2.48
THB
| Stock | |
| LEE ENTERPRISES, INCORPORATED | LEE | Nasdaq +2 Other | 11,846 |
12.45
USD
| Stock | |
| LEE ENTERPRISES, INCORPORATED | LE70 | Deutsche Boerse AG | - |
11.4
EUR
| ||
| LEE ENTERPRISES, INCORPORATED | LE70 | Börse Stuttgart | - |
11.2
EUR
| ||
| TEO GUAN LEE CORPORATION | TGL | BURSA MALAYSIA | 10,087 |
1.16
MYR
| Stock | |
| YEW LEE PACIFIC GROUP | YEWLEE | BURSA MALAYSIA | 10,511,073 |
0.425
MYR
| Stock | |
| CHING LEE HOLDINGS LIMITED | 3728 | Hong Kong S.E. | - |
0.078
HKD
| Stock | |
| YAU LEE HOLDINGS LIMITED | 406 | Hong Kong S.E. | - |
1.16
HKD
| Stock | |
| MUAR BAN LEE GROUP | MBL | BURSA MALAYSIA | 106,980 |
0.48
MYR
| Stock | |
| LEE SWEE KIAT GROUP | LEESK | BURSA MALAYSIA | 2,243,253 |
1.06
MYR
| Stock | |
| STAN LEE MEDIA, INC. | HULK | OTC Markets | 19 |
0.0006
USD
| Stock |
News (3149)
Companies (86)
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazym ...
Grupo Bimbo SAB de CV is a Mexico-based company engaged in the food processing sector. The Company focuses on the manufacture, distribution and sale of bread, breakfast bread muffins and bagels, frozen bread, cakes and smaller cakes, sweet and non-sweet c ...
KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The Company has developed a portfolio ...
Lee Hedges PLC is a Sri Lanka-based investment holding company. The principal activities of subsidiary companies are development of property, administration, and maintenance. The Companyâs wholly owned subsidiaries include Lee Hedges Investment Limited ...
Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. The Company's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for th ...
Shanghai Jin Jiang International Hotels Co Ltd, formerly Shanghai Jin Jiang International Hotels Development Co., Ltd., is a China-based company principally engaged in the operation and management of limited-service hotels. The hotel brands under the Comp ...
Teo Guan Lee Corporation Berhad is a Malaysia-based investment holding company. The Company is engaged in the provision of management services. The Company operates through two segments: Apparels and Investment holding. Apparels segment is engaged in manu ...
Qian Yuan Baixing, Inc., through Panjin Chunqiu Century Industrial Co., Ltd. (Chunqiu), is focused on selling goods and services on the Internet. The Company also, through Hangzhou Mai Jin Li Biotechnology Co., Ltd (Mai Jin Li), is an enterprise specializ ...
JINS HOLDINGS Inc., formerly JINS Inc is principally engaged in the eyewear business. The Company operates its business through three business segments. Domestic Eyewear segment and Overseas Eyewear segment are mainly engaged in the sale of eyeglasses, an ...
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE). ...
Insiders
Mr. Hae-Jin Lee is a Chairman at A Holdings Corp., a Global Investment Officer at NAVER Corp. and a Chief Executive Officer & Director at NHN Global Ltd. He is on the Board of Directors at NHN Global Ltd. and Naver Japan Corp. Mr. Lee was previously employed as a Non-Executive Director by NHN Entertainment Corp. He also served on the board at Line Plus Corp. He received his undergraduate degree from Seoul National University and a graduate degree from Korea Advanced Institute of Science & Technology.
Hae-Jin Jae is currently the Chief Executive Officer & Director at Blue Icon Co., Ltd.
and also serves as a Director at NEO TECHNICAL SYSTEM Co., Ltd.
He previously worked as a Director & Auditor at HMCIB No.
1 Special Purpose Acquisition Co. Mr. Jae is a graduate of Seoul National University.
No results for this search
- Stock Market
- Advanced search
- Hae-Jin Lee
